Analyst Insight
Athira Pharma Inc. (ATHA) Is Still A Worthy Bet Despite Risks
Following news of failed pharmacological trials, Athira Pharma Inc.’s (NASDAQ: ATHA) stock price dropped precipitously. However, management thinks that even these subpar outcomes may be